Literature DB >> 9259396

Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features.

K Ohshima1, J Suzumiya, A Kato, K Tashiro, M Kikuchi.   

Abstract

Lymph nodes from the incipient or early neoplastic phase of adult T-cell leukemia/lymphoma (ATLL) histologically resemble Hodgkin's disease. Integrated proviral human T-lymphotrophic virus type I (HTLV-I) has been demonstrated in such lesions. We studied 18 patients with this disease, and about half of the cases developed typical ATLL within 2 or 3 years. In all cases, either mono- or oligoclonal cell populations with proviral HTLV-I DNA were detected by Southern blot analysis and/or inverse polymerase chain reaction (IPCR). In addition, either a mono- or oligoclonal rearrangement of T-cell receptor genes was demonstrated. Giant cells with Reed-Sternberg-like histological features revealed CD15 and CD30 positivity. The background infiltrating lymphocytes represented either no or only minimal nuclear abnormalities with a CD4+ T-cell phenotype. In less than half of all cases, Epstein-Barr virus (EBV) infected the giant cells. A mixed EBV-A and -B type was found in 3, and a multiple genotype of EBV lymphocyte-determined membrane antigen (LYDMA) was found in 6 cases. These results could have been due to the immunodeficient status of the patients. A single-cell PCR of the giant cell, B cell, CD4+ or CD8+ T cells could be performed after cell sorting in 4 cases. HTLV-I infection was frequently found in the CD4+ T cells, but in neither the giant cells nor the B cells. The CD4+ T cells exhibited clonality. The giant cells showed various PCR products of IgH, and also expressed recombination activating genes (RAG). In summary, the giant cells were reactive cells, which resembled the immature B-lineage cells, while HTLV-I infected the CD4+ T cells, which demonstrated clonality. Based on these above findings, we consider CD4+ cells to play an important role in ATLL tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259396     DOI: 10.1002/(sici)1097-0215(19970807)72:4<592::aid-ijc7>3.0.co;2-l

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Adult T-cell leukemia/lymphoma with Epstein-Barr virus-positive Hodgkin-like cells.

Authors:  Girish Venkataraman; Jonathan Berkowitz; John C Morris; John E Janik; Mark A Raffeld; Stefania Pittaluga
Journal:  Hum Pathol       Date:  2011-02-11       Impact factor: 3.466

2.  Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.

Authors:  Kennosuke Karube; Mitsuyoshi Takatori; Shugo Sakihama; Yuma Tsuruta; Takashi Miyagi; Kazuho Morichika; Sakiko Kitamura; Norihiro Nakada; Masaki Hayashi; Shohei Tomori; Iwao Nakazato; Kazuiku Ohshiro; Naoki Imaizumi; Yara Yukie Kikuti; Naoya Nakamura; Satoko Morishima; Hiroaki Masuzaki; Takuya Fukushima
Journal:  Blood Adv       Date:  2021-01-12

Review 3.  Microenvironment of adult T-cell leukemia/lymphoma-associated nodal lesions.

Authors:  Koichi Ohshima; Daisuke Niino; Kennosuke Karube
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

4.  Differential diagnosis of angioimmunoblastic T-cell lymphoma with seropositivity for anti-HTLV antibody from adult T-cell leukemia/lymphoma.

Authors:  Shih-Sung Chuang; Ryo Ichinohasama; Jan-Show Chu; Koichi Ohshima
Journal:  Int J Hematol       Date:  2010-03-04       Impact factor: 2.490

5.  Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.

Authors:  Toshinari Yagi; Jun Ishikawa; Nana Aono; Yukiko Yamashita; Shinsuke Kusakabe; Tetsuhiro Yoshinami; Yuki Akazawa; Daisuke Sakai; Sachiko Yamamoto; Yuri Hamanaka; Hiroaki Masaie; Naotoshi Sugimoto; Hitoshi Yoshida; Yasuhiko Tomita; Fumio Imamura
Journal:  Int J Hematol       Date:  2011-12-16       Impact factor: 2.490

Review 6.  Hodgkin Lymphoma: Biology and Differential Diagnostic Problem.

Authors:  Taishi Takahara; Akira Satou; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Diagnostics (Basel)       Date:  2022-06-20

7.  Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells.

Authors:  William N Mwangi; Lorraine P Smith; Susan J Baigent; Richard K Beal; Venugopal Nair; Adrian L Smith
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

8.  Development of ultra-super sensitive immunohistochemistry and its application to the etiological study of adult T-cell leukemia/lymphoma.

Authors:  Kazuhisa Hasui; Jia Wang; Yuetsu Tanaka; Shuji Izumo; Yoshito Eizuru; Takami Matsuyama
Journal:  Acta Histochem Cytochem       Date:  2012-04-21       Impact factor: 1.938

9.  Dermatopathic reaction of lymph nodes in HTLV-1 carriers: a spectrum of reactive and neoplastic lesions.

Authors:  Shigeki Chinen; Takuya Miyagi; Yoshiya Murakami; Mitsuyoshi Takatori; Shugo Sakihama; Iwao Nakazato; Yoshiyuki Kariya; Sayaka Yamaguchi; Kenzo Takahashi; Kennosuke Karube
Journal:  Histopathology       Date:  2020-06-18       Impact factor: 5.087

10.  Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis.

Authors:  Yosuke Nakaya; Masahiro Yoshida; Minako Tsutsumi; Hoyuri Fuseya; Mirei Horiuchi; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Ki-Ryang Koh; Daisuke Niino; Takeshi Inoue; Takahisa Yamane
Journal:  J Clin Exp Hematop       Date:  2019-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.